Activation of peroxisome proliferator-activated receptor γ inhibits osteoprotegerin gene expression in human aortic smooth muscle cells
- 14 June 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 294 (3) , 597-601
- https://doi.org/10.1016/s0006-291x(02)00533-8
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Peroxisome Proliferator–Activated Receptor γ and Metabolic DiseaseAnnual Review of Biochemistry, 2001
- Control of Vascular Cell Proliferation and Migration by PPAR-γDiabetes Care, 2001
- Peroxisome proliferator–activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor–deficient miceJournal of Clinical Investigation, 2000
- Expression and Function of PPARγ in Rat and Human Vascular Smooth Muscle CellsCirculation, 2000
- Peroxisome proliferator‐activated receptors in the cardiovascular systemBritish Journal of Pharmacology, 2000
- Orphan Nuclear Receptors: Shifting Endocrinology into ReverseScience, 1999
- Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone DensityCell, 1997
- Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.Journal of Clinical Investigation, 1996
- Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptorsPublished by Elsevier ,1992
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990